Bluebird’s Fast Lyfgenia Launch Was A Year And A Half In The Making

Zynteglo Build Gives Firm A Leg Up In Sickle Cell Disease

 
• By Mandy Jackson
  
DNA helix 3D illustration. Mutations under microscope. Decoding genome.
Bluebird's sickle cell gene therapy Lyfgenia launched in January • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Gene Therapies

More from Advanced Therapies